Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSDClinicalTrials.gov · 2026-10-01Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studiesPharmacotherapy in Psychiatry and Neurology · 2026-09-29A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsClinicalTrials.gov · 2026-09-16A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)ClinicalTrials.gov · 2026-07-23Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open MIND · 2026-07-09Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.CNS & neurological disorders drug targets · 2026-03-11Psilocybin wirkt bei therapieresistenter DepressionDNP - Die Neurologie & Psychiatrie · 2026-02-01Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challengesAdvanced Neurology · 2025-12-04Psychedelic use in Poland: prevalence, correlates and social attitudes.Postepy psychiatrii neurologii · 2025-09-01The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2025-06-13Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)Neurology · 2025-04-07The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?Neurology Bulletin · 2025-03-14Psychedelics are Bringing a new wind to the PharmacopoeiaNeuroscience and Neurological Surgery · 2025-02-27Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreichInFo Neurologie + Psychiatrie · 2025-01-01Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.Frontiers in neurology · 2025-01-01Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyClinicalTrials.gov · 2024-12-04A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)ClinicalTrials.gov · 2024-08-15Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First RespondersClinicalTrials.gov · 2024-06-24[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].Fortschritte der Neurologie-Psychiatrie · 2024-06-01Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.Journal of the neurological sciences · 2024-05-15Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)Neurology · 2024-04-09Psilocybin und Funktionalität bei DepressionInFo Neurologie + Psychiatrie · 2023-08-01Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)ClinicalTrials.gov · 2023-07-06The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24[Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie-Psychiatrie · 2023-03-01Wirkt Psilocybin nachhaltig antidepressiv?InFo Neurologie + Psychiatrie · 2023-02-01A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive EmergencyJournal of the American Society of Nephrology · 2022-10-31Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)ClinicalTrials.gov · 2022-09-22The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini ReviewBrain and Neurological Disorders · 2022-06-19Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.Journal of the neurological sciences · 2022-03-15Mit Psilocybin gegen DepressionInFo Neurologie + Psychiatrie · 2021-08-01Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.European journal of neurology · 2021-07-314 Psychedelics: therapeutic mechanismsJournal of Neurology Neurosurgery & Psychiatry · 2020-07-20[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.Case reports in neurological medicine · 2017-01-01PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSISJournal of Neurology Neurosurgery & Psychiatry · 2013-08-06[Hallucinogen-induced psychological disorders].Fortschritte der Neurologie-Psychiatrie · 2008-06-01Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 85-100Psychiatria et Neurologia · 2008-05-06Klinische Erfahrungen mit Psilocybin (CY39 Sandoz)Psychiatria et Neurologia · 2008-05-06Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69-84Psychiatria et Neurologia · 2008-05-06Hallucinogen research inspires “neurotheology”The Lancet Neurology · 2006-08-17Response of cluster headache to psilocybin and LSD.Neurology · 2006-06-27[Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs].Revista de neurologia · 2003-01-01Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.The Journal of asthma research · 1965-09-01LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.The Journal of psychology · 1963-10-01Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.Neurology · 1962-09-01Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and PsilocybinThe Journal of Psychology · 1960-01-01